Caribou Biosciences, Inc.

Contributing Author

Recent Articles by Caribou Biosciences, Inc.

Nov-03	Caribou Biosciences to Participate in Upcoming Investor Conferences CRBU GlobeNewswire
Nov-03	Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma CRBU GlobeNewswire
Nov-03	Caribou Biosciences Announces Positive Data from ANTLER Phase 1 Trial Demonstrating Efficacy and Durability of Vispa-cel (CB-010), an Allogeneic CAR-T Cell Therapy, on Par with Autologous CAR-T Cell Therapies CRBU GlobeNewswire
Nov-02	Caribou Biosciences to Host Webcast to Report New Data Updates from Two Allogeneic CAR-T Cell Therapy Programs in Lymphoma and Multiple Myeloma CRBU GlobeNewswire
Aug-25	Caribou Biosciences to Participate in the Citi 2025 Biopharma Back to School Conference CRBU GlobeNewswire
Aug-12	Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update CRBU GlobeNewswire
May-28	Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference CRBU GlobeNewswire
May-08	Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update CRBU GlobeNewswire
May-06	Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference CRBU GlobeNewswire